戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 l basis for a putative role of sbGnRH as the gonadotropin-releasing hormone.
2 gonadotropes, and this effect is enhanced by gonadotropin-releasing hormone.
3  to provide an episodic, excitatory drive to gonadotropin-releasing hormone 1 (GnRH) neurons, the syn
4 nit, which is transcriptionally regulated by gonadotropin-releasing hormone 1 (GNRH).
5                                              Gonadotropin-releasing hormone 1 (GnRH1) from the brain
6 thalamic neurons that synthesize and release gonadotropin-releasing hormone 1 (GnRH1), but the precis
7                       Pulsatile secretion of gonadotropin-releasing hormone-1 (GnRH-1) is essential f
8 cystokinin (CCK) in the developing olfactory-gonadotropin-releasing hormone-1 (GnRH-1) neuroendocrine
9                                              Gonadotropin-releasing hormone-1 (GnRH-1) neurons migrat
10 asic ovarian sex hormone fluctuation using a gonadotropin-releasing hormone agonist (GnRHa) and evalu
11 rted previously that after 1-year follow up, gonadotropin-releasing hormone agonist (GnRHa) did not p
12 by surgical castration and those who receive gonadotropin-releasing hormone agonist (GnRHa) therapy.
13 nditions: ovarian suppression induced by the gonadotropin-releasing hormone agonist leuprolide acetat
14                          We administered the gonadotropin-releasing hormone agonist leuprolide acetat
15 umulation increased after treatment with the gonadotropin-releasing hormone agonist leuprolide, which
16                                              Gonadotropin-releasing hormone agonist therapy is associ
17 over study, 12 healthy, young males received gonadotropin-releasing hormone agonist treatment 1 month
18 ceptive use or progesterone treatment, prior gonadotropin-releasing hormone agonist treatment, and pr
19 nditions: ovarian suppression induced by the gonadotropin-releasing hormone agonist, leuprolide aceta
20 al women, or premenopausal women receiving a gonadotropin-releasing hormone agonist, with estrogen re
21 nmetastatic disease, intervention group with gonadotropin-releasing hormone agonist-based ADT, contro
22          The authors examined the effects of gonadotropin-releasing hormone agonist-induced ovarian s
23 othersome side effects than treatment with a gonadotropin-releasing hormone agonist.
24 efore and after treatment with a long-acting gonadotropin-releasing hormone agonist.
25  production was achieved with the use of the gonadotropin-releasing-hormone agonist triptorelin, ooph
26                                              Gonadotropin-releasing hormone agonists (GnRHa) have bee
27 herapies (OR, 4.04 [95% CI, 1.88-8.69]), and gonadotropin-releasing hormone agonists (OR, 1.93 [95% C
28  androgen deprivation therapy in the form of gonadotropin-releasing hormone agonists and newer antago
29                                              Gonadotropin-releasing hormone agonists decrease bone mi
30                                              Gonadotropin-releasing hormone agonists given with chemo
31 y a combined androgen blockade consisting of gonadotropin-releasing hormone agonists with oral antian
32 er treatments such as surgical oophorectomy, gonadotropin-releasing hormone agonists, chemotherapy-in
33 rized into 1 of 6 mutually exclusive groups: gonadotropin-releasing hormone agonists, oral antiandrog
34 ess of depot leuprolide acetate, a synthetic gonadotropin-releasing hormone analog (GnRH-a), for prot
35 of glucocorticoid replacement, 19.2%; and of gonadotropin-releasing hormone analog therapy, 34.2%.
36        Ten women (23 +/- 1 years) received a gonadotropin releasing hormone analogue (GnRHa), leuprol
37                                              Gonadotropin-releasing hormone analogue triptorelin, bil
38 rel-releasing intrauterine system (LNG-IUD), gonadotropin-releasing hormone analogues (GnRHa; nafarel
39                                              Gonadotropin-releasing hormone analogues and laparoscopi
40 n suppression (castration via orchiectomy or gonadotropin-releasing hormone analogues) suppresses cir
41                                              Gonadotropin-releasing hormone analogues, danazol, and d
42 399R) had attenuated secretion of endogenous gonadotropin-releasing hormone and a left-shifted dose-r
43 siveness to both exogenous gonadotropins and gonadotropin-releasing hormone and had normal levels of
44 ikely to be mediated by reduced secretion of gonadotropin-releasing hormone and our results support t
45          Moreover, ERbeta2 is coexpressed in gonadotropin-releasing hormone and oxytocin neurons.
46 onsiveness to the endogenous natural ligand, gonadotropin releasing hormone, and an agonist that is s
47                                              Gonadotropin releasing hormone antagonism successfully r
48 o the antral stage in both immature mice and gonadotropin releasing hormone antagonist-treated adult
49 differences in T through administration of a gonadotropin releasing hormone antagonist.
50  (ii) a single subcutaneous injection of the gonadotropin-releasing hormone antagonist (GnRH-A), acyl
51 le-stimulating hormone and administration of gonadotropin-releasing hormone antagonist to prevent pre
52 of short-term castration (1 month) using the gonadotropin-releasing hormone antagonist, Acyline, vers
53 been found for other classes of drugs (e.g., gonadotropin-releasing hormone antagonists, neurokinin r
54 tostatin agonists, urotensin II antagonists, gonadotropin-releasing hormone antagonists, neurotensin
55 e and a left-shifted dose-response curve for gonadotropin-releasing hormone as compared with six pati
56 h, and adrenal maturation, is initiated when gonadotropin-releasing hormone begins to be secreted by
57 levels are increased somewhat by exposure to gonadotropin-releasing hormone but are not necessarily l
58 e likely to be factors in the suppression of gonadotropin releasing hormone (GnRH) activity.
59  17beta-estradiol (E2) regulating release of gonadotropin releasing hormone (GnRH) and luteinizing ho
60 tress index, CSI), women self administered a gonadotropin releasing hormone (GnRH) antagonist for 16
61                   The complete Serine 8-type gonadotropin releasing hormone (GnRH) coding sequence wi
62 ntrolled in part by the pulsatile release of gonadotropin releasing hormone (GnRH) from the hypothala
63                                   Release of gonadotropin releasing hormone (GnRH) from the medial ba
64 stone deacetylases (HDACs) in the control of gonadotropin releasing hormone (GnRH) neuronal developme
65 odulate the central driver of fertility: the gonadotropin releasing hormone (GnRH) neuronal system.
66 gy balance and season, time the awakening of gonadotropin releasing hormone (GnRH) neurons at the ons
67 onadotropic hypogonadism to study effects of gonadotropin releasing hormone (GnRH) neurons on neurona
68 regions contain cell bodies and/or fibers of gonadotropin releasing hormone (GnRH) neurons, suggestin
69 tory receptor (ORNs), vomeronasal (VRNs) and gonadotropin releasing hormone (GnRH) neurons.
70                                              Gonadotropin releasing hormone (GnRH) plays an important
71 e associated with regulation by activins and gonadotropin releasing hormone (GnRH).
72 acetate, a synthetic nonapeptide analogue of gonadotropin-releasing hormone (GnRH or LHRH), is the ac
73                                              Gonadotropin-releasing hormone (GnRH) acts at gonadotrop
74  a potent and very long acting antagonist of gonadotropin-releasing hormone (GnRH) after subcutaneous
75 mone but apparently normal responsiveness to gonadotropin-releasing hormone (GnRH) agonist and antago
76          Androgen deprivation therapy with a gonadotropin-releasing hormone (GnRH) agonist is associa
77 bserved by MIS, which enhances the effect of gonadotropin-releasing hormone (GnRH) agonist on the FSH
78                                              Gonadotropin-releasing hormone (GnRH) agonists (e.g., tr
79 bjected to 26 ART treatment cycles receiving gonadotropin-releasing hormone (GnRH) agonists and recom
80                                              Gonadotropin-releasing hormone (GnRH) agonists are assoc
81                                              Gonadotropin-releasing hormone (GnRH) agonists decrease
82                                              Gonadotropin-releasing hormone (GnRH) agonists decrease
83                        Studies of the use of gonadotropin-releasing hormone (GnRH) agonists to protec
84 n were on antiandrogens (AA), 26,959 were on gonadotropin-releasing hormone (GnRH) agonists, and 3,74
85 ective randomized trial evaluated the use of gonadotropin-releasing hormone (GnRH) analog triptorelin
86                                      Because gonadotropin-releasing hormone (GnRH) analogs constitute
87                           Women treated with gonadotropin-releasing hormone (GnRH) analogs may develo
88  estrogens, finasteride, spironolactone, and gonadotropin-releasing hormone (GnRH) analogs.
89                                         Both gonadotropin-releasing hormone (GnRH) and activins, memb
90 ted with oocyte meiosis, TGF-beta signaling, gonadotropin-releasing hormone (GnRH) and epidermal grow
91                              In vertebrates, gonadotropin-releasing hormone (GnRH) and gonadotropin-i
92 and controls the synthesis and/or release of gonadotropin-releasing hormone (GnRH) and gonadotropins.
93 ons are thought to regulate the secretion of gonadotropin-releasing hormone (GnRH) and thus coordinat
94               Elagolix, an oral, nonpeptide, gonadotropin-releasing hormone (GnRH) antagonist, produc
95               Based on the SAR from bicyclic gonadotropin-releasing hormone (GnRH) antagonists such a
96                         Neurons that produce gonadotropin-releasing hormone (GnRH) are the final comm
97 amining the distribution of cells containing gonadotropin-releasing hormone (GnRH) as well as estroge
98 male rat preoptic area (POA), containing the gonadotropin-releasing hormone (GnRH) cell bodies, treat
99 ypothalamic-pituitary-ovarian axis, in which gonadotropin-releasing hormone (GnRH) controls the relea
100                                     Isolated gonadotropin-releasing hormone (GnRH) deficiency caused
101 othalamic amenorrhea is a reversible form of gonadotropin-releasing hormone (GnRH) deficiency commonl
102                                              Gonadotropin-releasing hormone (GnRH) deficiency in the
103                                   Congenital gonadotropin-releasing hormone (GnRH) deficiency manifes
104                         Neurons that produce gonadotropin-releasing hormone (GnRH) drive the reproduc
105                                     In mice, gonadotropin-releasing hormone (GnRH) expression is limi
106                   The pulsatile secretion of gonadotropin-releasing hormone (GnRH) from normal and im
107  been established that episodic secretion of gonadotropin-releasing hormone (GnRH) from the hypothala
108  Individuals with an inherited deficiency in gonadotropin-releasing hormone (GnRH) have impaired sexu
109  action on puberty by stimulating release of gonadotropin-releasing hormone (GnRH) in the hypothalamu
110 levated levels of transcripts for the salmon gonadotropin-releasing hormone (GnRH) in the male telenc
111                            Administration of gonadotropin-releasing hormone (GnRH) induces a surge of
112 that FOXO1 repressed basal transcription and gonadotropin-releasing hormone (GnRH) induction of both
113 amic median eminence (ME) where they release gonadotropin-releasing hormone (GnRH) into a specialized
114                                 Hypothalamic gonadotropin-releasing hormone (GnRH) is a decapeptide t
115                                              Gonadotropin-releasing hormone (GnRH) is a key regulator
116                                              Gonadotropin-releasing hormone (GnRH) is a neuropeptide
117                                              Gonadotropin-releasing hormone (GnRH) is a trophic pepti
118                                              Gonadotropin-releasing hormone (GnRH) is a trophic pepti
119 propriate tissue-specific gene expression of gonadotropin-releasing hormone (GnRH) is critical for pu
120                              In vertebrates, gonadotropin-releasing hormone (GnRH) is essential to th
121                                              Gonadotropin-releasing hormone (GnRH) is exclusively exp
122                                              Gonadotropin-releasing hormone (GnRH) is found in a wide
123 n of ERK1/2 by the hypothalamic neuropeptide gonadotropin-releasing hormone (GnRH) is relatively sust
124                                              Gonadotropin-releasing hormone (GnRH) is released in a p
125                         Pulsatile release of gonadotropin-releasing hormone (GnRH) is required for fe
126                The hypothalamic neuropeptide gonadotropin-releasing hormone (GnRH) is secreted in a p
127                                              Gonadotropin-releasing hormone (GnRH) is secreted in bri
128                                              Gonadotropin-releasing hormone (GnRH) is secreted in bri
129                                              Gonadotropin-releasing hormone (GnRH) is the central reg
130                                              Gonadotropin-releasing hormone (GnRH) is the central reg
131                                              Gonadotropin-releasing hormone (GnRH) is the central reg
132                                          The gonadotropin-releasing hormone (GnRH) is the master regu
133                                          The gonadotropin-releasing hormone (GnRH) is the master regu
134                We have previously shown that gonadotropin-releasing hormone (GnRH) ligand-independent
135                                          The gonadotropin-releasing hormone (GnRH) neuron is the pivo
136                   An attractive model is the gonadotropin-releasing hormone (GnRH) neuron system, mas
137  (RFRP-3) neurons have been shown to inhibit gonadotropin-releasing hormone (GnRH) neuronal activity
138  a profound influence on the activity of the gonadotropin-releasing hormone (GnRH) neuronal network c
139                 Estradiol feedback regulates gonadotropin-releasing hormone (GnRH) neurons and subseq
140                                              Gonadotropin-releasing hormone (GnRH) neurons are born i
141                                              Gonadotropin-releasing hormone (GnRH) neurons are critic
142                                              Gonadotropin-releasing hormone (GnRH) neurons are neuroe
143                                              Gonadotropin-releasing hormone (GnRH) neurons are neuroe
144                                              Gonadotropin-releasing hormone (GnRH) neurons are the ce
145                                              Gonadotropin-releasing hormone (GnRH) neurons are the ce
146                                              Gonadotropin-releasing hormone (GnRH) neurons are the fi
147                                              Gonadotropin-releasing hormone (GnRH) neurons are the fi
148                                          The gonadotropin-releasing hormone (GnRH) neurons are the ke
149                                              Gonadotropin-releasing hormone (GnRH) neurons are the pr
150 sspeptin neurons act cooperatively to excite gonadotropin-releasing hormone (GnRH) neurons during pos
151                                              Gonadotropin-releasing hormone (GnRH) neurons exhibit bu
152                                              Gonadotropin-releasing hormone (GnRH) neurons form the f
153 al axis is dependent on correct migration of gonadotropin-releasing hormone (GnRH) neurons from the n
154 oductive functioning in mammals depends upon gonadotropin-releasing hormone (GnRH) neurons generating
155  in mice for controlling the activity of the gonadotropin-releasing hormone (GnRH) neurons in vivo to
156                                 Hypothalamic gonadotropin-releasing hormone (GnRH) neurons integrate
157 ut from the suprachiasmatic nucleus (SCN) to gonadotropin-releasing hormone (GnRH) neurons is critica
158                               Secretion from gonadotropin-releasing hormone (GnRH) neurons is necessa
159                                              Gonadotropin-releasing hormone (GnRH) neurons migrate fr
160                                              Gonadotropin-releasing hormone (GnRH) neurons originate
161                                              Gonadotropin-releasing hormone (GnRH) neurons produce th
162                                              Gonadotropin-releasing hormone (GnRH) neurons represent
163 n, rostral projections from the AVPV contact gonadotropin-releasing hormone (GnRH) neurons surroundin
164 onstructions and electrophysiology, that the gonadotropin-releasing hormone (GnRH) neurons that contr
165 rculating estradiol on proestrus to activate gonadotropin-releasing hormone (GnRH) neurons that, in t
166 estradiol (E2) regulates the activity of the gonadotropin-releasing hormone (GnRH) neurons through bo
167 nisms through which estradiol (E2) regulates gonadotropin-releasing hormone (GnRH) neurons to control
168 s how nerve terminal Ca(2+) is controlled in gonadotropin-releasing hormone (GnRH) neurons via action
169 peptin regulates reproduction by stimulating gonadotropin-releasing hormone (GnRH) neurons via the ki
170                                              Gonadotropin-releasing hormone (GnRH) neurons, a small n
171  mice lacking necdin have reduced numbers of gonadotropin-releasing hormone (GnRH) neurons, but the m
172 eactive fibres also abut the preoptic-septal gonadotropin-releasing hormone (GnRH) neurons, suggestin
173 siological processes including activation of gonadotropin-releasing hormone (GnRH) neurons, the neura
174 ne hormone secretion, especially that of the gonadotropin-releasing hormone (GnRH) neurons, via neura
175 arcuate nucleus (Arc) provide tonic drive to gonadotropin-releasing hormone (GnRH) neurons, which in
176 o a developmental defect in the migration of gonadotropin-releasing hormone (GnRH) neurons.
177 l pathways contain cell bodies and fibers of gonadotropin-releasing hormone (GnRH) neurons.
178 ARH)), which drive the pulsatile activity of gonadotropin-releasing hormone (GnRH) neurons.
179 TEMENT The brain regulates fertility through gonadotropin-releasing hormone (GnRH) neurons.
180 f reproduction by acting on gonadotropes and gonadotropin-releasing hormone (GnRH) neurons.
181 icating abnormal steroid hormone feedback to gonadotropin-releasing hormone (GnRH) neurons.
182 , is enriched in cilia projecting from mouse gonadotropin-releasing hormone (GnRH) neurons.
183 o adulthood and depends upon the activity of gonadotropin-releasing hormone (GnRH) neurons.
184 yclicity, including long-acting analogues of gonadotropin-releasing hormone (GnRH) or oestradiol (adm
185     Most cells are immunoreactive for either gonadotropin-releasing hormone (GnRH) or RF-amide-like p
186                                              Gonadotropin-releasing hormone (GnRH) plays a central ro
187                                 Hypothalamic gonadotropin-releasing hormone (GnRH) plays a critical r
188 ty of kisspeptin-10 to elicit the release of gonadotropin-releasing hormone (GnRH) precociously, and
189 genes are expressed under the control of the gonadotropin-releasing hormone (GnRH) promoter has made
190                  Convergent evolution of the gonadotropin-releasing hormone (GnRH) receptor (GnRHR) p
191          Efforts to develop orally available gonadotropin-releasing hormone (GnRH) receptor antagonis
192                                          The gonadotropin-releasing hormone (GnRH) receptor is a drug
193                                    The human gonadotropin-releasing hormone (GnRH) receptor is evolut
194                                              Gonadotropin-releasing hormone (GnRH) receptor mutants f
195 o and caused cell death in cells bearing the gonadotropin-releasing hormone (GnRH) receptor, we could
196 ion as a measure of information transfer via gonadotropin-releasing hormone (GnRH) receptors (GnRHR)
197                                Activation of gonadotropin-releasing hormone (GnRH) receptors inhibits
198 have specialized adaptations associated with gonadotropin-releasing hormone (GnRH) regulation to opti
199           NMDA and kisspeptins can stimulate gonadotropin-releasing hormone (GnRH) release after peri
200                                    Pulsatile gonadotropin-releasing hormone (GnRH) release is critica
201                            A robust surge of gonadotropin-releasing hormone (GnRH) release triggers t
202 ing hormone, the latter reflecting increased gonadotropin-releasing hormone (GnRH) release.
203  important in modulating the tonic pulsatile gonadotropin-releasing hormone (GnRH) release.
204  of reproduction by brain-secreted pulses of gonadotropin-releasing hormone (GnRH) represents a longs
205                         Neurons that produce gonadotropin-releasing hormone (GnRH) reside in the basa
206 otropic hypogonadism (IHH) due to defects of gonadotropin-releasing hormone (GnRH) secretion and/or a
207         Ovulation is initiated by a surge of gonadotropin-releasing hormone (GnRH) secretion by the b
208           Acquisition of a mature pattern of gonadotropin-releasing hormone (GnRH) secretion from the
209                                              Gonadotropin-releasing hormone (GnRH) secretion is regul
210  in the regulation of pubertal and adulthood gonadotropin-releasing hormone (GnRH) secretion, and mut
211 wn to be key components in the regulation of gonadotropin-releasing hormone (GnRH) secretion.
212 try regulating estrogen negative feedback on gonadotropin-releasing hormone (GnRH) secretion.
213 uctive development and for the regulation of gonadotropin-releasing hormone (GnRH) secretion.
214 plicated in the neuroendocrine regulation of gonadotropin-releasing hormone (GnRH) secretion.
215 ic hypogonadism had a measurable response to gonadotropin-releasing hormone (GnRH) stimulation, sugge
216                                     A robust gonadotropin-releasing hormone (GnRH) surge is a prerequ
217 lmann syndrome is an inherited deficiency of gonadotropin-releasing hormone (GnRH) that is characteri
218 sulting in a massive release of hypothalamic gonadotropin-releasing hormone (GnRH) that peaks within
219 rmal puberty promotes the central release of gonadotropin-releasing hormone (GnRH) that, in turn, lea
220 revealed that IKK-beta and NF-kappaB inhibit gonadotropin-releasing hormone (GnRH) to mediate ageing-
221                  The binding of hypothalamic gonadotropin-releasing hormone (GnRH) to the pituitary G
222 itary gonadotropin hormones are regulated by gonadotropin-releasing hormone (GnRH) via MAPK signaling
223 duce ciliated neurons that express genes for gonadotropin-releasing hormone (GnRH), a G-protein-coupl
224 ) designed to express an antibody that binds gonadotropin-releasing hormone (GnRH), a master regulato
225  and negative modulators drives secretion of gonadotropin-releasing hormone (GnRH), a neuropeptide th
226  (MCH), thyrotropin-releasing hormone (TRH), gonadotropin-releasing hormone (GnRH), and kisspeptin.
227  brain controls fertility through release of gonadotropin-releasing hormone (GnRH), but the mechanism
228 he FSHbeta subunit is primarily regulated by gonadotropin-releasing hormone (GnRH), gonadal steroids,
229  under the control of pulsatile hypothalamic gonadotropin-releasing hormone (GnRH), is essential for
230       Pubertal onset, initiated by pulsatile gonadotropin-releasing hormone (GnRH), only occurs in a
231 pite of the fact that hypothalamic levels of gonadotropin-releasing hormone (GnRH), pituitary release
232  sprouting in hypothalamic neurons secreting gonadotropin-releasing hormone (GnRH), the neuropeptide
233 blished that hypothalamic neurons, including gonadotropin-releasing hormone (GnRH), VP, OT, beta-endo
234                              The decapeptide gonadotropin-releasing hormone (GnRH), which regulates r
235 ndent upon the appropriate neurosecretion of gonadotropin-releasing hormone (GnRH), yet the endogenou
236                                              Gonadotropin-releasing hormone (GnRH)-expressing neurons
237              Mammalian reproduction requires gonadotropin-releasing hormone (GnRH)-mediated signaling
238 lamic-pituitary-gonadal axis is dependent on gonadotropin-releasing hormone (GNRH)-stimulated synthes
239 ontrols reproduction in mammals by secreting gonadotropin-releasing hormone (GnRH).
240  neural network that drives the secretion of gonadotropin-releasing hormone (GnRH).
241 or action of the master reproductive hormone gonadotropin-releasing hormone (GnRH).
242 etic disorders associated with deficiency of gonadotropin-releasing hormone (GnRH).
243 genital defect in the secretion or action of gonadotropin-releasing hormone (GnRH).
244 in the pituitary gonadotrope by hypothalamic gonadotropin-releasing hormone (GnRH).
245 n mammals by secreting the 'master molecule' gonadotropin-releasing hormone (GnRH).
246 e a class of neuroendocrine cells containing gonadotropin-releasing hormone (GnRH).
247 ted as an increase in pulsatile secretion of gonadotropin-releasing hormone (GnRH).
248                                 They secrete gonadotropin-releasing hormone (GnRH-1), communicate wit
249 rmone-releasing hormone (LHRH, also known as gonadotropin-releasing hormone [GnRH]), a key neurohormo
250 e reproduction requires pulsatile release of gonadotropin-releasing hormone (GnRH1) from the hypothal
251 In mammals, the receptor of the neuropeptide gonadotropin-releasing hormone (GnRHR) is unique among t
252  basis of selectivity of naturally occurring gonadotropin-releasing hormones (GnRHs) from different s
253                                              Gonadotropin-releasing hormone-I (GnRH-I) cells are loca
254 r fibers were observed in close proximity to gonadotropin-releasing hormone-I, dopamine, beta-endorph
255 ing hormone-I, dopamine, beta-endorphin, and gonadotropin-releasing hormone-II neurons in the preopti
256 n-releasing hormone and had normal levels of gonadotropin-releasing hormone in the hypothalamus.
257  a neuropeptide homologous to the vertebrate gonadotropin-releasing hormone, is downregulated as work
258 ty and infertility as a result of defects in gonadotropin-releasing hormone neuron development or fun
259 st gonadotropin responses, suggesting normal gonadotropin-releasing hormone neuronal and gonadotrope
260 ive control, including direct innervation of gonadotropin releasing hormone neurons.
261 se neurons also precede the emergence of the gonadotropin-releasing hormone neurons and ensheathing g
262 lamic nucleus and send axonal projections to gonadotropin-releasing hormone neurons and regulate repr
263                     In immortalized immature gonadotropin-releasing hormone neurons endogenously expr
264   Notably, TRPC1 suppressed the migration of gonadotropin-releasing hormone neurons without affecting
265 Z formed appositions with orexin neurons and gonadotropin-releasing hormone neurons, two cell populat
266 ive Ca(2+) imaging in the nerve terminals of gonadotropin-releasing hormone neurons.
267 ed hypothalamic cells and immortalized GnRH (gonadotropin-releasing hormone) neurons (GT1-7 cells) tr
268 g hormone, growth hormone-releasing hormone, gonadotropin-releasing hormone, oxytocin, somatostatin,
269 g that this receptor is essential for normal gonadotropin-releasing hormone physiology and for pubert
270 cant relation between the number of doses of gonadotropin-releasing hormone received during the 12 mo
271                       Pharmacoperones of the gonadotropin releasing hormone receptor (GnRHR) have eff
272 ere designed and synthesized as potent human gonadotropin releasing hormone receptor antagonists.
273                                          The gonadotropin releasing hormone receptor, because of its
274 in-conjugated gold nanorods (gGNRs) promotes gonadotropin releasing hormone receptor-mediated interna
275 eptide agonists and antagonists of the human gonadotropin-releasing hormone receptor (GnRH-R) are wid
276 eurons (GT1-7 cells), agonist binding to the gonadotropin-releasing hormone receptor (GnRH-R) causes
277  of a series thienopyrimidinediones with the gonadotropin-releasing hormone receptor (GnRH-R).
278  targeting of tumor cells overexpressing the gonadotropin-releasing hormone receptor (GnRH-R).
279 r reproductive traits, growth hormone (GHR), gonadotropin-releasing hormone receptor (GNRHR) and neur
280                 Long-term suppression of the gonadotropin-releasing hormone receptor (GnRHR) is an im
281                                          The gonadotropin-releasing hormone receptor (GnRHR) is expre
282 on in pedigree 1 and a compound heterozygous gonadotropin-releasing hormone receptor (GNRHR) mutation
283 icipate in partitioning mutant conformers of gonadotropin-releasing hormone receptor (GnRHR), a G pro
284 mines bearing a butyric acid as potent human gonadotropin-releasing hormone receptor (hGnRH-R) antago
285 he C-terminal domains of either GluR1 or the gonadotropin-releasing hormone receptor permits efficien
286 y of several potent antagonists of the human gonadotropin-releasing hormone receptor.
287 regulation (reduced pituitary sensitivity to gonadotropin-releasing hormone), reduced conception rate
288 oter activity, highlighting a role of SET in gonadotropin-releasing hormone regulation of gene expres
289  from the Kiss1 promoter disrupted pulsatile gonadotropin-releasing hormone release, delayed puberty
290                                 Three prepro-gonadotropin-releasing hormones, seabream GnRH (sbGnRH),
291                    Gene expression of salmon gonadotropin-releasing hormone (sGnRH) and NR1 increased
292 ns, suggesting sensitization of the NKB-NK3R-gonadotropin-releasing hormone signaling pathway under m
293 nsgenic mice, and is released in response to gonadotropin-releasing hormone, similar to LH.
294 lular: oxytocin, vasopressin; parvicellular: gonadotropin-releasing hormone, somatostatin, thyrotropi
295  these two factors is essential in mediating gonadotropin-releasing hormone stimulation of LHbeta pro
296  androgen receptors, and by the hypothalamic gonadotropin-releasing hormone through activation of PKA
297 olic, and other factors control secretion of gonadotropin-releasing hormone to determine initiation o
298 uires the pulsatile, coordinated delivery of gonadotropin-releasing hormone to the pituitary and the
299                  Responsiveness to exogenous gonadotropin-releasing hormone was assessed in both the
300 uctive function requires timely secretion of gonadotropin-releasing hormone, which is controlled by a

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top